"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about VIRAMUNE
• Ask Community about VIRAMUNE
• VIRAMUNE Usage
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

VIRAMUNE Safety Questions, VIRAMUNE Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about VIRAMUNE. Our extensive database of VIRAMUNE adverse events and VIRAMUNE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about VIRAMUNE

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

VIRAMUNE Safety Reports

Total VIRAMUNE reports: 254.
VIRAMUNE FDA safety alerts: 2004 2005 .
Reported deaths: 42    Reported hospitalizations: 132.
Take VIRAMUNE Side Effects Survey or Share Your VIRAMUNE Story. VIRAMUNE Usage.

< Previous  Showing 151-225 of 254 Next >

Physician from reported VIRAMUNE problem on May 22, 2002. Female patient, weighting 11.90 lb, was diagnosed with vertical infection transmission and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: convulsion, convulsion neonatal, hyperlactacidaemia, hypotonia neonatal, neutropenia, neutropenia neonatal. VIRAMUNE dosage: unknown. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Physician from FRANCE on Dec 14, 2000. Male patient, weighting 6.61 lb, was diagnosed with prophylaxis against hiv infection, diarrhoea and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: anaemia, anaemia neonatal, hypertriglyceridaemia, neutropenia, neutropenia neonatal. VIRAMUNE dosage: unknown. During the same period patient was treated with RETROVIR, VIDEX, VITAMINS, ERCEFURYL. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported VIRAMUNE problem on Dec 14, 2000. Male patient, weighting 7.21 lb, was diagnosed with prophylaxis against hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: anaemia macrocytic, caesarean section, hyperlactacidaemia. VIRAMUNE dosage: unknown. During the same period patient was treated with RETROVIR, EPIVIR, SUSTIVA, COMBIVIR. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Physician from FRANCE on Dec 22, 2000. Male patient, weighting 15.43 lb, was diagnosed with prophylaxis against hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: anaemia neonatal, caesarean section, gastrooesophageal reflux disease, hydrocephalus, necrotising enterocolitis neonatal, premature baby, strabismus. VIRAMUNE dosage: 4 MG/KG/DAY. During the same period patient was treated with RETROVIR, CRIXIVAN, COMBIVIR. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported VIRAMUNE problem on Oct 23, 2000. Male patient, weighting 7.50 lb, was diagnosed with human immunodeficiency virus transmission, hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, caesarean section, gastrointestinal haemorrhage, haematochezia, hypertriglyceridaemia, neutropenia. VIRAMUNE dosage: unknown. During the same period patient was treated with VIDEX, ZERIT, CRIXIVAN, NORVIR, SUSTIVA, COMBIVIR, INVIRASE. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Physician from FRANCE on Mar 13, 2001. Male patient, weighting 6.75 lb, was diagnosed with human immunodeficiency virus transmission, hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hyperkalaemia, lactic acidosis, metabolic acidosis, neonatal disorder. VIRAMUNE dosage: unknown. During the same period patient was treated with RETROVIR, COMBIVIR. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported VIRAMUNE problem on Feb 16, 2001. Male patient, weighting 4.19 lb, was diagnosed with human immunodeficiency virus transmission, hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: anaemia, sickle cell anaemia. VIRAMUNE dosage: unknown. During the same period patient was treated with CLAMOXYL, VIDEX, SAQUINAVIR, RITONAVIR, RETROVIR. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Physician from on June 15, 2001. Female patient, weighting 6.61 lb, was diagnosed with human immunodeficiency virus transmission, hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: blood ketone body increased, blood lactic acid increased, hepatosplenomegaly, hypertriglyceridaemia, lactate pyruvate ratio increased, neutropenia. VIRAMUNE dosage: unknown. During the same period patient was treated with VIDEX, INVIRASE, NORVIR, SUSTIVA, VIRACEPT, RETROVIR. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported VIRAMUNE problem on Dec 14, 2000. Male patient, weighting 6.61 lb, was diagnosed with prophylaxis against hiv infection, diarrhoea and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, anaemia, developmental delay, hyperlactacidaemia, hypertriglyceridaemia, neonatal disorder, neutropenia, speech disorder developmental. VIRAMUNE dosage: unknown. During the same period patient was treated with RETROVIR, VIDEX, VITAMINS, ERCEFURYL. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Physician from FRANCE on Oct 23, 2000. Male patient, weighting 7.50 lb, was diagnosed with human immunodeficiency virus transmission, hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, caesarean section, communication disorder, depression, gastrointestinal disorder. VIRAMUNE dosage: unknown. During the same period patient was treated with VIDEX, ZERIT, CRIXIVAN, NORVIR, SUSTIVA, COMBIVIR, INVIRASE. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported VIRAMUNE problem on Jan 02, 2002. Male patient was diagnosed with prophylaxis against hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, blood lactic acid increased, convulsion, grand mal convulsion, growth retardation, weight gain poor. VIRAMUNE dosage: 10 MG/ML. During the same period patient was treated with RETROVIR. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Physician from FRANCE on Jan 03, 2003. Female patient, weighting 7.05 lb, was diagnosed with prophylaxis against hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: bradycardia, caesarean section, malaise, pallor, syncope vasovagal. VIRAMUNE dosage: unknown. During the same period patient was treated with VIDEX, EPIVIR, KALETRA. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported VIRAMUNE problem on Oct 27, 1999. Female patient, weighting 7.05 lb, was diagnosed with prophylaxis against hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: anaemia, blood lactic acid increased, herpes zoster, hypertriglyceridaemia, hypotonia neonatal, maternal condition affecting foetus, neonatal disorder, neutropenia. VIRAMUNE dosage: unknown. During the same period patient was treated with RETROVIR, VIDEX, INVIRASE, SUSTIVA, ZERIT, NORVIR. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Physician from UNITED STATES on Nov 15, 2006. Male patient, 52 years of age, weighting 175.0 lb, was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: asthenia, atrial fibrillation, dyspnoea, dyspnoea exertional, lactic acidosis, mitochondrial toxicity. VIRAMUNE dosage: unknown. During the same period patient was treated with ATRIPLA, TRUVADA. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported VIRAMUNE problem on June 26, 2001. Female patient, weighting 6.61 lb, was diagnosed with human immunodeficiency virus transmission, hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: blood lactic acid increased, hypertriglyceridaemia, neutropenia. VIRAMUNE dosage: unknown. During the same period patient was treated with VIDEX, INVIRASE, NORVIR, SUSTIVA, VIRACEPT, RETROVIR. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Consumer or non-health professional from ZIMBABWE on June 23, 2006. Female patient, 39 years of age, weighting 125.4 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: neutropenia, pneumonia. VIRAMUNE dosage: unknown. During the same period patient was treated with TENOFOVIR, EMTRICITABINE. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported VIRAMUNE problem on Dec 14, 2000. Male patient, weighting 7.21 lb, was diagnosed with prophylaxis against hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: anaemia macrocytic, blood creatine phosphokinase increased, blood ketone body increased, blood pyruvic acid increased, caesarean section, developmental delay, hyperlactacidaemia, lactic acidosis. VIRAMUNE dosage: unknown. During the same period patient was treated with RETROVIR, EPIVIR, SUSTIVA, COMBIVIR. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Health Professional from BOTSWANA on Dec 08, 2006. Female patient, weighting 6.11 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: skin hypopigmentation, umbilical hernia. VIRAMUNE dosage: unknown. During the same period patient was treated with EPIVIR, ZERIT. Patient recovered.

Physician from FRANCE reported VIRAMUNE problem on Dec 14, 2000. Male patient, weighting 7.21 lb, was diagnosed with prophylaxis against hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: anaemia macrocytic, blood creatine phosphokinase increased, blood ketone body increased, caesarean section, hyperlactacidaemia, lactate pyruvate ratio increased, lactic acidosis, platelet count increased. VIRAMUNE dosage: unknown. During the same period patient was treated with RETROVIR, EPIVIR, SUSTIVA, COMBIVIR. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Consumer or non-health professional from FRANCE on Oct 30, 2000. Male patient, weighting 167.6 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: cytolytic hepatitis, eosinophilia, hypersensitivity, pyrexia, rash. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized and became disabled. Patient recovered.

Health Professional from BOTSWANA reported VIRAMUNE problem on Dec 11, 2006. Male patient, weighting 6.94 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: congenital anomaly, limb reduction defect. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR, SUSTIVA. Patient recovered.

VIRAMUNE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 22, 2006. Male patient, 50 years of age, weighting 105.8 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: blister, cheilitis, laboratory test abnormal, palpitations, psychotic disorder, skin reaction, stevens-johnson syndrome. VIRAMUNE dosage: unknown. During the same period patient was treated with EMTRICITABINE, TENOFOVIR DF, FERROUS SULPHATE, EFAVIRENZ. Patient died on 11/13/2006.

Physician from FRANCE reported VIRAMUNE problem on Dec 18, 2006. Female patient, weighting 125.7 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: hyperplasia, lymphadenitis, pruritus, pyrexia, rash, rash maculo-papular, scratch. VIRAMUNE dosage: unknown. During the same period patient was treated with BACTRIM, TRUVADA, SPECIAFOLDINE, DIFFU K, TARDYFERON, ARANESP. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Physician from on July 03, 2007. Male patient, weighting 5.29 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: ascites, cardiomyopathy, cytomegalovirus infection, developmental delay, foetal-maternal haemorrhage, haemoglobin decreased, hydrops foetalis, pericardial effusion. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR. Patient recovered.

Consumer or non-health professional from ZIMBABWE reported VIRAMUNE problem on July 05, 2007. Male patient, weighting 8.82 lb, was diagnosed with human immunodeficiency virus transmission and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: sepsis neonatal. VIRAMUNE dosage: unknown. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Health Professional from BOTSWANA on July 03, 2007. Female patient, 28 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: abortion induced. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR, ZERIT, EPIVIR. Patient recovered.

Physician from FRANCE reported VIRAMUNE problem on July 03, 2007. Female patient, weighting 198.4 lb, was diagnosed with prophylaxis against hiv infection, depression, dyslipidaemia and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: leukocytoclastic vasculitis. VIRAMUNE dosage: unknown. During the same period patient was treated with TENORMIN, EFFEXOR, LYPANTHYL, XANAX, LUTENYL, COMBIVIR. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Health Professional from UNITED KINGDOM on July 05, 2007. Female patient, 31 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: stillbirth. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR. Patient recovered.

Consumer or non-health professional from THAILAND reported VIRAMUNE problem on July 10, 2007. Female patient, weighting 78.26 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: rash. VIRAMUNE dosage: unknown. During the same period patient was treated with INDINAVIR, RITONAVIR. Patient recovered.

VIRAMUNE problem was reported by a Physician from UNITED STATES on July 09, 2007. Female patient, 31 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: stillbirth. VIRAMUNE dosage: unknown. During the same period patient was treated with SUSTIVA, TRUVADA. Patient recovered.

Pharmacist from UNITED STATES reported VIRAMUNE problem on May 10, 2007. Female patient, 25 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. VIRAMUNE dosage: unknown. During the same period patient was treated with ATRIPLA, TRUVADA, NORVIR, REYATAZ. Patient recovered.

VIRAMUNE problem was reported by a Physician from UNITED STATES on July 13, 2007. Female patient, 38 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR. Patient recovered.

Consumer or non-health professional from reported VIRAMUNE problem on July 06, 2007. Female patient, weighting 136.7 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: asthenia, cytolytic hepatitis, headache, hyperthermia, inflammation, jaundice, myalgia, pruritus. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Consumer or non-health professional from FRANCE on July 17, 2007. Female patient, weighting 6.06 lb, was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: accidental overdose, anaemia, hyperlactacidaemia, neutropenia. VIRAMUNE dosage: unknown. During the same period patient was treated with VIRACEPT, CRIXIVAN, NORVIR, COMBIVIR, RETROVIR, ZIDOVUDINE. Patient was hospitalized. Patient recovered.

Physician from reported VIRAMUNE problem on July 17, 2007. Male patient, weighting 168.7 lb, was diagnosed with hiv infection, hyperlipidaemia and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: leukocytoclastic vasculitis. VIRAMUNE dosage: unknown. During the same period patient was treated with EPIVIR, TENOFOVIR, PRAVASTATIN. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Physician from UNITED STATES on July 20, 2007. Female patient, 31 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: stillbirth. VIRAMUNE dosage: unknown. During the same period patient was treated with SUSTIVA, TRUVADA. Patient recovered.

Pharmacist from UNITED STATES reported VIRAMUNE problem on July 20, 2007. Female patient, 25 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. VIRAMUNE dosage: unknown. During the same period patient was treated with ATRIPLA, TRUVADA, NORVIR, REYATAZ. Patient recovered.

VIRAMUNE problem was reported by a Health Professional from on July 26, 2007. Female patient, weighting 6.72 lb, was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: congenital anomaly, haemangioma. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR, ASPIRIN, CLEXANE. Patient recovered.

Consumer or non-health professional from reported VIRAMUNE problem on July 25, 2007. Female patient, weighting 136.7 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: asthenia, c-reactive protein increased, cytolytic hepatitis, headache, hyperthermia, jaundice, myalgia, pruritus. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Physician from UNITED STATES on July 31, 2007. Female patient, 31 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: stillbirth. VIRAMUNE dosage: unknown. During the same period patient was treated with SUSTIVA, TRUVADA. Patient recovered.

Health Professional from UNITED STATES reported VIRAMUNE problem on Aug 06, 2007. Female patient, 22 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. VIRAMUNE dosage: unknown. During the same period patient was treated with KALETRA, TRUVADA. Patient recovered.

VIRAMUNE problem was reported by a Consumer or non-health professional from UGANDA on Aug 08, 2007. Male patient, weighting 13.23 lb, was diagnosed with prophylaxis against hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: bronchopneumonia, cardiopulmonary failure. VIRAMUNE dosage: unknown. During the same period patient was treated with COTRIM, ORAL REHYDRATION SALTS. Patient was hospitalized. Patient died on 07/11/2007.

Consumer or non-health professional from UNITED STATES reported VIRAMUNE problem on Aug 08, 2007. Female patient, weighting 6.61 lb, was diagnosed with vertical infection transmission and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: blood bicarbonate decreased, blood creatinine increased. VIRAMUNE dosage: unknown. During the same period patient was treated with ZIDOVUDINE, DIDANOSINE, VITAMIN K1. Patient recovered.

VIRAMUNE problem was reported by a Physician from FRANCE on Aug 08, 2007. Female patient, 43 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: cholangitis, portal hypertension. VIRAMUNE dosage: unknown. During the same period patient was treated with VIDEX, IRBESARTAN, EPIVIR. Patient recovered.

Physician from UNITED STATES reported VIRAMUNE problem on Aug 10, 2007. Male patient, 39 years of age, weighting 167.6 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: liver function test abnormal, rash. VIRAMUNE dosage: unknown. Patient recovered.

VIRAMUNE problem was reported by a Consumer or non-health professional from KENYA on Aug 17, 2007. Female patient, 46 years of age, weighting 91.49 lb, was diagnosed with hiv infection, malaria and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, mental status changes, renal failure acute. VIRAMUNE dosage: unknown. During the same period patient was treated with TRUVADA, COTRIM, PLASIL, FANSIDAR. Patient died on 08/02/2007.

Consumer or non-health professional from reported VIRAMUNE problem on Aug 13, 2007. Female patient, weighting 136.7 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: asthenia, c-reactive protein increased, cytolytic hepatitis, headache, hyperthermia, jaundice, myalgia, pruritus. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized. Patient recovered.

VIRAMUNE problem was reported by a Health Professional from UNITED STATES on Aug 16, 2007. Female patient, 30 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: liver function test abnormal. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR. Patient recovered.

Consumer or non-health professional from UGANDA reported VIRAMUNE problem on Aug 22, 2007. Male patient, weighting 13.23 lb, was diagnosed with prophylaxis against hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: bronchopneumonia, cardiopulmonary failure. VIRAMUNE dosage: unknown. During the same period patient was treated with COTRIM, ORAL REHYDRATION SALTS. Patient was hospitalized. Patient died on 07/11/2007.

VIRAMUNE problem was reported by a Physician from UNITED STATES on Aug 20, 2007. Female patient, 31 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: stillbirth. VIRAMUNE dosage: unknown. During the same period patient was treated with SUSTIVA, TRUVADA. Patient recovered.

Health Professional from UNITED STATES reported VIRAMUNE problem on Aug 22, 2007. Female patient, 28 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: abortion induced. VIRAMUNE dosage: unknown. Patient recovered.

VIRAMUNE problem was reported by a Health Professional from UNITED STATES on Aug 22, 2007. Female patient, 29 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. VIRAMUNE dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported VIRAMUNE problem on Aug 22, 2007. Female patient, weighting 5.91 lb, was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: atrioventricular septal defect. VIRAMUNE dosage: unknown. Patient recovered.

VIRAMUNE problem was reported by a Health Professional from UNITED STATES on Aug 22, 2007. Female patient, 32 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. VIRAMUNE dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported VIRAMUNE problem on Aug 22, 2007. Female patient, 38 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: ectopic pregnancy. VIRAMUNE dosage: unknown. During the same period patient was treated with SUSTIVA, ABACAVIR. Patient recovered.

VIRAMUNE problem was reported by a Health Professional from UNITED STATES on Aug 22, 2007. Female patient, 24 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. VIRAMUNE dosage: unknown. During the same period patient was treated with NELFINAVIR. Patient recovered.

Health Professional from UNITED STATES reported VIRAMUNE problem on Aug 22, 2007. Female patient, 35 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: abortion induced. VIRAMUNE dosage: unknown. Patient recovered.

VIRAMUNE problem was reported by a Health Professional from UNITED STATES on Aug 22, 2007. Female patient, 25 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. VIRAMUNE dosage: unknown. During the same period patient was treated with SUSTIVA, TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.

Health Professional from UNITED STATES reported VIRAMUNE problem on Aug 22, 2007. Female patient, 29 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: stillbirth. VIRAMUNE dosage: unknown. During the same period patient was treated with SUSTIVA. Patient recovered.

VIRAMUNE problem was reported by a Health Professional from UNITED STATES on Aug 22, 2007. Female patient, 33 years of age, was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: abortion induced. VIRAMUNE dosage: unknown. During the same period patient was treated with NELFINAVIR. Patient recovered.

Health Professional from UNITED STATES reported VIRAMUNE problem on Aug 22, 2007. Female patient, 28 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: abortion induced. VIRAMUNE dosage: unknown. Patient recovered.

VIRAMUNE problem was reported by a Health Professional from UNITED STATES on Aug 22, 2007. Female patient, 24 years of age, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous. VIRAMUNE dosage: unknown. Patient recovered.

Consumer or non-health professional from reported VIRAMUNE problem on Aug 23, 2007. Female patient was diagnosed with human immunodeficiency virus transmission, prophylaxis and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: neutropenia, weight decreased. VIRAMUNE dosage: 2 MG/KG (10 MG/ML). During the same period patient was treated with ZIDOVUDINE. Patient recovered.

VIRAMUNE problem was reported by a Consumer or non-health professional from on Aug 23, 2007. Female patient was diagnosed with human immunodeficiency virus transmission, prophylaxis and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, neutropenia, pyrexia, septic shock, vomiting. VIRAMUNE dosage: 2 MG/KG (10 MG/ML). During the same period patient was treated with ZIDOVUDINE. Patient died.

Consumer or non-health professional from reported VIRAMUNE problem on Aug 23, 2007. Female patient was diagnosed with human immunodeficiency virus transmission, prophylaxis and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: neutropenia, pneumonia aspiration. VIRAMUNE dosage: 2 MG/KG (10 MG/ML). During the same period patient was treated with ZIDOVUDINE. Patient died.

VIRAMUNE problem was reported by a Consumer or non-health professional from on Aug 23, 2007. Female patient was diagnosed with human immunodeficiency virus transmission, prophylaxis and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, neutropenia. VIRAMUNE dosage: 2 MG/KG (10 MG/ML). During the same period patient was treated with ZIDOVUDINE. Patient died.

Health Professional from UNITED STATES reported VIRAMUNE problem on Aug 22, 2007. Female patient, weighting 2.20 lb, was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: joint dislocation. VIRAMUNE dosage: unknown. During the same period patient was treated with ABACAVIR, NELFINAVIR, SAQUINAVIR. Patient recovered.

VIRAMUNE problem was reported by a Physician from on Aug 28, 2007. Male patient, weighting 5.29 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: ascites, cardiomyopathy, cytomegalovirus infection, developmental delay, foetal-maternal haemorrhage, haemoglobin decreased, hydrops foetalis, pericardial effusion. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR. Patient recovered.

Consumer or non-health professional from KENYA reported VIRAMUNE problem on Aug 31, 2007. Female patient, 46 years of age, weighting 91.49 lb, was diagnosed with hiv infection, antiemetic supportive care, malaria and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, mental status changes, renal failure acute. VIRAMUNE dosage: unknown. During the same period patient was treated with TRUVADA, COTRIM, PLASIL, FANSIDAR. Patient died on 08/02/2007.

VIRAMUNE problem was reported by a Consumer or non-health professional from FRANCE on Aug 30, 2007. Female patient, weighting 136.7 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: asthenia, c-reactive protein increased, cytolytic hepatitis, headache, hyperthermia, jaundice, myalgia, pruritus. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported VIRAMUNE problem on Aug 21, 2007. Male patient, weighting 174.2 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: arthralgia, fatigue, jaundice, liver function test abnormal, malaise, myalgia, pharyngolaryngeal pain, pyrexia, rash erythematous. VIRAMUNE dosage: unknown. During the same period patient was treated with TRUVADA, VALTREX. Patient recovered.

VIRAMUNE problem was reported by a Physician from FRANCE on Aug 31, 2007. Female patient, weighting 172.0 lb, was diagnosed with hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, stillbirth. VIRAMUNE dosage: unknown. During the same period patient was treated with COMBIVIR. Patient recovered.

Health Professional from UNITED STATES reported VIRAMUNE problem on Sept 04, 2007. Female patient, weighting 5.91 lb, was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: atrioventricular septal defect. VIRAMUNE dosage: unknown. Patient recovered.

VIRAMUNE problem was reported by a Health Professional from UNITED STATES on Sept 04, 2007. Female patient, weighting 2.20 lb, was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: joint dislocation. VIRAMUNE dosage: unknown. During the same period patient was treated with ABACAVIR, NELFINAVIR, SAQUINAVIR. Patient recovered.

Consumer or non-health professional from ZIMBABWE reported VIRAMUNE problem on Sept 04, 2007. Female patient, weighting 8.82 lb, was diagnosed with prophylaxis against hiv infection and was treated with VIRAMUNE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, crying, heart rate increased, jaundice, neonatal infective mastitis, neutrophil count decreased, ophthalmia neonatorum, pneumonia, tachypnoea. VIRAMUNE dosage: unknown. Patient was hospitalized. Patient recovered.

< Previous  Showing 151-225 of 254 Next >

Ask Our Patient Community about VIRAMUNE
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide) Omniscan (gadodiamide) OptiMARK (gadoversetamide) Optison (perflutren protein-type A microspheres)